Olsen Birthe S, Lilleøre Søren Kruse, Korsholm Conny Nøhr, Kracht Thorben
Department of Pediatrics, Glostrup University Hospital, Glostrup, Denmark.
J Diabetes Sci Technol. 2010 Nov 1;4(6):1468-75. doi: 10.1177/193229681000400622.
Despite advances in insulin pen design and functionality, the selection of pens available for children with diabetes is limited. This study assessed the usability, functionality and attitudes towards NovoPen Echo®, a new durable insulin pen designed for pediatric patients that combines a simple memory function with half-increment dosing, versus NovoPen® Junior and HumaPen® Luxura™ HD in pediatric subjects, their parents, and health care professionals (HCPs).
Pens were evaluated in random order during 1:1 interviews in the three target groups (pediatric subjects, parents, and HCPs) in Germany, France, and Canada. Study participants were asked to prepare each pen, perform injections into foam cushions, and provide feedback via a standardized questionnaire.
In total, 205 participants were included in the study. On a scale of 1-6 (1=most favorable; 6=least favorable regarding overall appearance, shape, colors, thickness and length), NovoPen Echo received the most favorable rating for design and overall appearance (mean±standard deviation=1.71±0.79) compared with NovoPen Junior (2.02±0.93) and HumaPen Luxura HD (2.36±1.01). Furthermore, 89% of pediatric subjects and 94% of parents rated the memory function of NovoPen Echo as very easy/easy to use. When asked to rate the pens overall, 80% of participants preferred NovoPen Echo to the other pens (p<0.0001).
The results demonstrate a high overall level of satisfaction with NovoPen Echo among pediatric subjects, parents, and HCPs. The novel design aspects of NovoPen Echo, namely the simple memory function, half-increment units and, ease of use and design, may contribute towards promoting treatment adherence, which is essential in the pediatric setting.
尽管胰岛素笔的设计和功能有所进步，但可供糖尿病儿童使用的笔的选择仍然有限。本研究评估了NovoPen Echo®（一种专为儿科患者设计的新型耐用胰岛素笔，它将简单的记忆功能与半单位剂量给药相结合）与NovoPen® Junior和HumaPen® Luxura™ HD相比，在儿科患者、他们的父母以及医疗保健专业人员（HCPs）中的可用性、功能性和态度。
在德国、法国和加拿大对三个目标群体（儿科患者、父母和HCPs）进行一对一访谈期间，以随机顺序对胰岛素笔进行评估。研究参与者被要求准备每支笔，对泡沫垫进行注射，并通过标准化问卷提供反馈。
该研究共纳入205名参与者。在1至6分的评分量表（1分表示最满意；6分表示对整体外观、形状、颜色、粗细和长度最不满意）上，与NovoPen Junior（2.02±0.93）和HumaPen Luxura HD（2.36±1.01）相比，NovoPen Echo在设计和整体外观方面获得了最有利的评分（均值±标准差=1.71±0.79）。此外，89%的儿科患者和94%的父母认为NovoPen Echo的记忆功能非常容易/易于使用。当被要求对胰岛素笔进行总体评分时，80%的参与者更喜欢NovoPen Echo而不是其他笔（p<0.0001）。
结果表明，儿科患者、父母和HCPs对NovoPen Echo的总体满意度很高。NovoPen Echo的新颖设计特点，即简单的记忆功能、半单位剂量、易用性和设计，可能有助于促进治疗依从性，这在儿科环境中至关重要。
